Missed GME or NVDA? Don’t Miss the Next One.​
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
WAT Stock Forecast 2025-2026
$347.36
Current Price
$20.68B
Market Cap
Buy 7
Hold 15
Sell 0
Wall St Analyst Ratings
Distance to WAT Price Targets
+32.4%
To High Target of $460.00
+7.8%
To Median Target of $374.50
-1.2%
To Low Target of $343.11
WAT Price Momentum
-1.2%
1 Week Change
+5.0%
1 Month Change
-0.4%
1 Year Change
-6.4%
Year-to-Date Change
-18.0%
From 52W High of $423.56
+24.4%
From 52W Low of $279.24
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Waters (WAT) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on WAT and similar high-potential opportunities.
Latest WAT Stock Price Targets & Analyst Predictions
Based on our analysis of 23 Wall Street analysts, WAT has a neutral consensus with a median price target of $374.50 (ranging from $343.11 to $460.00). The overall analyst rating is Buy (7.2/10). Currently trading at $347.36, the median forecast implies a 7.8% upside. This outlook is supported by 7 Buy, 15 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Paul Knight at Keybanc, projecting a 32.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
WAT Analyst Ratings
7
Buy
15
Hold
0
Sell
WAT Price Target Range
Low
$343.11
Average
$374.50
High
$460.00
Current: $347.36
Latest WAT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for WAT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 7, 2025 | Baird | Catherine Ramsey | Outperform | Maintains | $374.00 |
| May 7, 2025 | UBS | Elizabeth Garcia | Neutral | Maintains | $360.00 |
| Apr 22, 2025 | Baird | Catherine Ramsey | Outperform | Maintains | $355.00 |
| Apr 10, 2025 | Barclays | Luke Sergott | Equal-Weight | Maintains | $350.00 |
| Mar 31, 2025 | Keybanc | Paul Knight | Overweight | Upgrade | $460.00 |
| Mar 26, 2025 | Baird | Catherine Ramsey | Outperform | Upgrade | $407.00 |
| Mar 6, 2025 | JP Morgan | Rachel Vatnsdal | Neutral | Maintains | $390.00 |
| Feb 13, 2025 | UBS | Elizabeth Garcia | Neutral | Maintains | $410.00 |
| Feb 13, 2025 | Wells Fargo | Brandon Couillard | Overweight | Maintains | $420.00 |
| Feb 13, 2025 | Scotiabank | Sung Ji Nam | Sector Outperform | Upgrade | $450.00 |
| Feb 13, 2025 | B of A Securities | Derik De Bruin | Neutral | Maintains | $410.00 |
| Feb 10, 2025 | Barclays | Luke Sergott | Equal-Weight | Upgrade | $415.00 |
| Dec 23, 2024 | Scotiabank | Sung Ji Nam | Sector Perform | Initiates | $430.00 |
| Dec 13, 2024 | B of A Securities | Derik De Bruin | Neutral | Maintains | $430.00 |
| Nov 4, 2024 | TD Cowen | Dan Brennan | Hold | Maintains | $410.00 |
| Nov 4, 2024 | Deutsche Bank | Justin Bowers | Hold | Maintains | $325.00 |
| Nov 4, 2024 | Wells Fargo | Brandon Couillard | Overweight | Maintains | $415.00 |
| Nov 4, 2024 | JP Morgan | Rachel Vatnsdal | Neutral | Maintains | $380.00 |
| Nov 4, 2024 | Stifel | Daniel Arias | Hold | Maintains | $360.00 |
| Nov 4, 2024 | Bernstein | Eve Burstein | Market Perform | Maintains | $360.00 |
Waters Corporation (WAT) Competitors
The following stocks are similar to Waters based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Waters Corporation (WAT) Financial Data
Waters Corporation has a market capitalization of $20.68B with a P/E ratio of 31.6x. The company generates $2.98B in trailing twelve-month revenue with a 22.0% profit margin.
Revenue growth is +3.9% quarter-over-quarter, while maintaining an operating margin of +22.9% and return on equity of +40.8%.
Valuation Metrics
Market Cap
$20.68B
Enterprise Value
$21.83B
P/E Ratio
31.6x
PEG Ratio
26.9x
Price/Sales
6.9x
Growth & Margins
Revenue Growth (YoY)
+3.9%
Gross Margin
+58.2%
Operating Margin
+22.9%
Net Margin
+22.0%
EPS Growth
+18.8%
Financial Health
Cash/Price Ratio
+1.9%
Current Ratio
1.8x
Debt/Equity
78.6x
ROE
+40.8%
ROA
+11.6%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Waters Corporation (WAT) Business Model
About Waters Corporation
What They Do
Provides analytical instruments and software solutions.
Business Model
The company generates revenue by selling high-performance liquid chromatography, mass spectrometry systems, and related technologies to various industries, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. Its products enhance laboratory productivity and support advanced research, contributing to drug development and quality control.
Additional Information
Waters Corporation operates globally and serves a diverse clientele, including academic institutions, government agencies, and private industries. The company's focus on innovation and precision positions it as a key player in advancing scientific research and technological development across critical sectors.
Company Information
Sector
Healthcare
Industry
Diagnostics & Research
Employees
7,600
CEO
Dr. Udit Batra Ph.D.
Country
United States
IPO Year
1995
Website
www.waters.comWaters Corporation (WAT) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
May 19, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Waters Corporation (NYSE: WAT) has acquired Halo Labsâ„¢, enhancing its capabilities in imaging technologies for detecting particles in therapeutic products.
Why It Matters
The acquisition enhances Waters Corporation's capabilities in biotech, potentially increasing market share and driving growth in therapeutic product development, positively impacting stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Waters Corp, a U.S. medical equipment manufacturer, reports increased demand from Indian drugmakers developing weight-loss drugs, according to a senior executive.
Why It Matters
Increased demand for Waters Corp's medical equipment from Indian drugmakers signals growth potential in the weight-loss drug market, potentially boosting the company's revenue and stock performance.
Source: Reuters
Market Sentiment:
Positive
Quick Summary
Waters Corporation (NYSE: WAT) has announced Udit Batra, Ph.D. as part of its leadership, effective May 16, 2025. Further details on his role were not provided.
Why It Matters
Udit Batra's appointment at Waters Corporation may signal strategic shifts or innovations, potentially impacting the company's performance and stock value.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Waters raised its annual profit forecast following strong Q1 results, driven by increased demand for medical instruments in Asia and the Americas.
Why It Matters
Waters' raised profit forecast signals strong performance and demand growth, indicating potential for higher returns and investor confidence in the company's future prospects.
Source: Reuters
Market Sentiment:
Positive
Quick Summary
Waters Corporation (NYSE: WAT) will hold its Q1 2025 earnings conference call on May 6, 2025, at 8:00 AM ET, featuring key executives and analysts from major firms.
Why It Matters
Waters Corporation's Q1 2025 earnings call provides insights into financial performance and strategic direction, influencing investor sentiment and stock valuation.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Waters Corporation's stock is rated "Hold." Q1 2025 saw 3.9% revenue and 18% EPS growth, but high valuations persist. Management anticipates high single-digit revenue growth ahead.
Why It Matters
Waters Corporation's high valuation limits stock upside despite solid earnings growth. Future potential hinges on market opportunities, but current prices may deter new investments.
Source: Seeking Alpha
Market Sentiment:
Positive
Frequently Asked Questions About WAT Stock
What is Waters Corporation's (WAT) stock forecast for 2025?
Based on our analysis of 23 Wall Street analysts, Waters Corporation (WAT) has a median price target of $374.50. The highest price target is $460.00 and the lowest is $343.11.
Is WAT stock a good investment in 2025?
According to current analyst ratings, WAT has 7 Buy ratings, 15 Hold ratings, and 0 Sell ratings. The stock is currently trading at $347.36. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for WAT stock?
Wall Street analysts predict WAT stock could reach $374.50 in the next 12 months. This represents a 7.8% increase from the current price of $347.36. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Waters Corporation's business model?
The company generates revenue by selling high-performance liquid chromatography, mass spectrometry systems, and related technologies to various industries, including pharmaceuticals, healthcare, food and beverage, and chemical analysis. Its products enhance laboratory productivity and support advanced research, contributing to drug development and quality control.
What is the highest forecasted price for WAT Waters Corporation?
The highest price target for WAT is $460.00 from Paul Knight at Keybanc, which represents a 32.4% increase from the current price of $347.36.
What is the lowest forecasted price for WAT Waters Corporation?
The lowest price target for WAT is $343.11 from at , which represents a -1.2% decrease from the current price of $347.36.
What is the overall WAT consensus from analysts for Waters Corporation?
The overall analyst consensus for WAT is neutral. Out of 23 Wall Street analysts, 7 rate it as Buy, 15 as Hold, and 0 as Sell, with a median price target of $374.50.
How accurate are WAT stock price projections?
Stock price projections, including those for Waters Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 22, 2025 7:45 PM UTC